Erythema nodosum (EN) is a delayed hypersensitivity response that may be triggered by a range of conditions, including infections and vaccines. Rare cases of EN caused by COVID-19 were recently reported but none due to COVID-19 vaccines were documented. We report here a case of EN occurring after COVID-19 vaccination. Patient presented with painful nodular lesions of all 4 limbs, evolving for one month. These lesions appeared 48 h after the second dose of COVID-19 vaccination. The patient reported no recent infectious episodes. The physical examination found numerous, erythematous dermohypodermatitis knots with no palpable adenopathy. Some were regressive according to biligenesis shades. Biology and radiology findings eliminated other common causes of this dermatosis. The skin biopsy was done and suggested EN. The final diagnosis was post COVID-19 vaccine EN. Patient received a symptomatic treatment and had a slight improvement of the lesions 10 days after diagnosis. Physicians should be aware of the side effects of the vaccine including skin manifestations, especially since more people are bound to be vaccinated.
References
[1]
Schwartz, R.A. and Nervi, S.J. (2007) Erythema Nodosum: A Sign of Systemic Disease. American Family Physician, 75, 695-700.
[2]
Ordieres-Ortega, L., Toledo-Samaniego, N., Parra-Virto, A., Fernández-Carracedo, E., Lavilla-Olleros, C. and Demelo-Rodríguez, P. (2020) Atypical Erythema Nodosum in a Patient with COVID-19 Pneumonia. Dermatologic Therapy, 33, e13658. https://doi.org/10.1111/dth.13658
[3]
Suter, P., Mooser, B. and Thien, H.P. (2020) Erythema Nodosum as a Cutaneous Manifestation of COVID-19 Infection. BMJ Case Reports, 13, e236613. https://doi.org/10.1136/bcr-2020-236613
[4]
Cribier, B., Caille, A., Heid, E. and Grosshans, E. (1998) Erythema Nodosum and Associated Diseases. A Study of 129 Cases. International Journal of Dermatology, 37, 667-672. https://doi.org/10.1046/j.1365-4362.1998.00316.x
[5]
Blake, T., Manahan, M. and Rodins, K. (2014) Erythema Nodosum—A Review of an Uncommon Panniculitis. Dermatology Online Journal, 20, 22376. https://doi.org/10.5070/D3204022376
[6]
Requena, L. and Yus, E.S. (2008) Erythema Nodosum. Dermatologic Clinics, 26, 425-438. https://doi.org/10.1016/j.det.2008.05.014
[7]
Rachadi, H., Ramli, I., Senouci, K., Hassam, B. and Ismaili, N. (2015) érythème noueux induit par l’imatinib : Un cas confirmé par une épreuve de réintroduction positive. Annales de Dermatologie et de Vénéréologie, 142, S694. https://doi.org/10.1016/j.annder.2015.10.568
[8]
Goolsby, P.L. (1989) Erythema Nodosum after Recombivax HB Hepatitis B Vaccine. The New England Journal of Medicine, 321, 1198-1199. https://doi.org/10.1056/NEJM198910263211717
[9]
Thomson, B.J. and Nuki, G. (1985) Erythema Nodosum Following Typhoid Vaccination. Scottish Medical Journal, 30, 173. https://doi.org/10.1177/003693308503000310
[10]
Doffoel-Hantz, V., Hantz, S., Souyri, N., Nouaille, Y., Bédane, C. and Sparsa, A. (2009) Erythème Noueux Induit par le Gardasil®. La Revue de Médecine Interne, 30, S131-S132. https://doi.org/10.1016/j.revmed.2009.03.291
[11]
Longueville, C., Doffoel-Hantz, V., Hantz, S., Souyri, N., Nouaille, Y., Bédane, C., et al. (2012) érythème Noueux Induit par le Gardasil®. La Revue de Médecine Interne, 33, e17-e18. https://doi.org/10.1016/j.revmed.2011.02.013
[12]
Wang, J., Peng, Y., Xu, H., Cui, Z. and Williams, R.O. (2020) The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech, 21, Article No. 225. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405756/ https://doi.org/10.1208/s12249-020-01744-7
[13]
McGonagle, D., Sharif, K., O’Regan, A. and Bridgewood, C. (2020) The Role of Cytokines Including Interleukin-6 in COVID-19 Induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmunity Reviews, 19, Article ID: 102537. https://doi.org/10.1016/j.autrev.2020.102537
[14]
Prompetchara, E., Ketloy, C. and Palaga, T. (2020) Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned from SARS and MERS Epidemic. Asian Pacific Journal of Allergy and Immunology, 38, 1-9.
[15]
Amoli, M.M., Miranda-Filloy, J.A., Vazquez-Rodriguez, T.R., Ollier, W.E.R. and Gonzalez-Gay, M.A. (2011) Interleukin-1 Beta Gene Polymorphism in Patients with Biopsy-Proven Erythema Nodosum. Clinical and Experimental Rheumatology, 29, S131-S132.
[16]
Amoli, M.M., Miranda-Filloy, J.A., Fernandez-Diaz, M.L., Martin, J., Ollier, W.E.R. and Gonzalez-Gay, M.A. (2008) Interleukin-6 Promoter Polymorphism at Position -174 in Biopsy-Proven Patients with Erythema Nodosum from a Defined Population. Clinical and Experimental Rheumatology, 26, S155-S156.
[17]
De Simone, C., Caldarola, G., Scaldaferri, F., Petito, V., Perino, F., Arena, V., et al. (2016) Clinical, Histopathological, and Immunological Evaluation of a Series of Patients with Erythema nodosum. International Journal of Dermatology, 55, e289-e294. https://doi.org/10.1111/ijd.13212
